Zacks Investment Research lowered shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) from a buy rating to a hold rating in a research note released on Tuesday morning.
According to Zacks, “Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company’s operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California. “
Separately, B. Riley reaffirmed a buy rating and set a $4.00 price target on shares of Ekso Bionics Holdings in a report on Wednesday, May 10th.
Ekso Bionics Holdings (NASDAQ:EKSO) traded down 1.29% on Tuesday, hitting $2.30. The stock had a trading volume of 505,407 shares. Ekso Bionics Holdings has a 1-year low of $0.99 and a 1-year high of $6.62. The firm’s 50-day moving average price is $1.61 and its 200-day moving average price is $3.11. The firm’s market cap is $58.96 million.
Ekso Bionics Holdings (NASDAQ:EKSO) last released its quarterly earnings results on Tuesday, May 9th. The company reported ($0.38) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.03. Ekso Bionics Holdings had a negative return on equity of 788.27% and a negative net margin of 392.15%. The firm had revenue of $1.44 million during the quarter, compared to analysts’ expectations of $2.38 million. On average, equities research analysts predict that Ekso Bionics Holdings will post ($1.25) earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Cut to Hold at Zacks Investment Research” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.com-unik.info/2017/07/17/ekso-bionics-holdings-inc-nasdaqekso-cut-to-hold-at-zacks-investment-research.html.
A hedge fund recently raised its stake in Ekso Bionics Holdings stock. Carl Domino Inc raised its position in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 262.4% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 46,966 shares of the company’s stock after buying an additional 34,008 shares during the period. Carl Domino Inc owned 0.21% of Ekso Bionics Holdings worth $193,000 at the end of the most recent quarter. 4.41% of the stock is owned by hedge funds and other institutional investors.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Ekso Bionics Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Ekso Bionics Holdings Inc. and related companies.